Pavol Pobeha, Pavol Joppa, Ružena Tkáčová
Chronic obstructive pulmonary disease (COPD) is a global disease with increasing morbidity and mortality worldwide.
The natural history of COPD is punctuated by acute exacerbations which have a major implications on patients
health status, lung funtion decline, quality of life and prognosis. The standard treatment in primary care
includes increasing short acting bronchodilator therapy and systemic glucocorticosteroids with or without antibiotics.
However, a minority of patients require hospital admissions and in these patients treatment of respiratory
insufficiency should be considered.